| Literature DB >> 31451464 |
Kamal Kant Sahu1, Deepali Pandey1, Ajay Kumar Mishra1, James O'Shea2, Yayan Chen3, Bradley McGregor4.
Abstract
We present the case of a 55-year-old male patient who presented with palpable cervical lymphadenopathy. Excisional biopsy showed metastatic adenocarcinoma of unknown origin. Imaging showed a bladder mass following which he underwent transurethral resection of bladder tumour. Histopathological evaluation of mass confirmed a poorly differentiated adenocarcinoma with signet-ring cell features. Immunohistochemistry was suggestive of metastatic urachal cancer. He agreed for enrollment in a clinical trial, however soon after 1st cycle, he developed immune pneumonitis requiring high dose steroids. On follow-up, MRI brain was done for evaluation of headache which showed metastatic intracranial disease. He completed radiotherapy following which he was started on FOLFOX chemo regimen (folinic acid, 5-fluorouracil and oxaliplatin). © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: cancer intervention; malignant disease and immunosuppression; radiology (diagnostics)
Mesh:
Substances:
Year: 2019 PMID: 31451464 DOI: 10.1136/bcr-2019-230215
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X